Читать книгу Pathy's Principles and Practice of Geriatric Medicine - Группа авторов - Страница 82

1 1. Lipsky MS, King M. Biological theories of aging. Disease‐a‐Month. 2015; 61(11):460–466.

2 2. Jin K. Modern biological theories of aging. Aging and Disease. 2010; 1(2):72.

3 3. Gems D, L. Partridge, Genetics of longevity in model organisms: debates and paradigm shifts. Annual Review of Physiology. 2013; 75:621–644.

4 4. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961; 25:585–621

5 5. Moskalev AA, Shaposhnikov MV, Plyusnina EN, Zhavoronkov A, Budovsky A, Yanai H, Fraifeld VE. The role of DNA damage and repair in aging through the prism of Koch‐like criteria. Ageing Res Rev. 2012. Published online.

6 6. Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet. 2012; 13:693–704.

7 7. Fraga MF, Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet. 2007; 23:413–418.

8 8. Lopez‐Otın C, A Blasco M, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013; 153:1194–1217.

9 9. Burke SN, Barnes CA. Neural plasticity in the ageing brain. Nature Reviews Neuroscience. 2006; 7:30–40.

10 10. Hendrickson SG. Nervous system. In: Lewis SL, Heitkemper MM, Dirksen SR, O’Brien PG, Bucher L, eds. Medical–Surgical Nursing. 7th ed. Mosby Elsevier; 2007:1441–1466.

11 11. Kaszniak AW, Menchola M. Behavioral neuroscience of emotion in aging. In: Pardon M, Bondi M, eds. Behavioral Neurobiology of Aging: Current Topics in Behavioral Neuroscience. Vol. 10. Springer; 2012:51–66.

12 12. Agnati L, Zolim F, Grlimadi R, et al. Cellular and synaptic alterations in the aging brain. Aging. 1990; 2:5–25.

13 13. Poirier J, Finch CE. Neurochemistry of the aging human brain. In: Hazzard WR, Bierman EL, Blass JP, Ettinger WH, Halter JB, eds. Principles of Geriatric Medicine and Gerontology. 3rd ed. McGraw‐Hill; 1994:1005–1012.

14 14. Kevorkian RT, Morley JE. The physiology of ageing. In: Sinclair AJ, Morley JE, Vellas B, eds. Pathy’s Principles and Practice of Geriatric Medicine. 5th ed. John Wiley and Sons, Ltd. Wiley‐Blackwell; 2012:38.

15 15. O’Brien M. Aids to Examination of the Peripheral Nervous System. Saunders; 2010.

16 16. Verrillo RT, Bolanowski SJ, Gescheider GA. Effect of aging on the subjective magnitude of vibration. Somatosens Mot Res. 2012; 19:238–244.

17 17. Folstein MF, Folstein SE, McHugh PR. Mini‐mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189–198.

18 18. Borson S, Scanlan J, Brush M, et al. The mini‐cog: a cognitive ‘vital signs’ measure for dementia screening in multi‐lingual elderly. Int J Geriatr Psychiatry. 2000; 15:1021–1027.

19 19. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53:695–699.

20 20. Olivetti G, Giordano G, Corradi D, et al. Gender differences and aging: effects on the human heart. J Am Coll Cardiol. 1995; 26:1068–1079.

21 21. Strait JB, Lakatta EG. Ageing‐associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin. 2012; 8:143–164.

22 22. Marzetti E, Csiszar A, Dutta D. Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics. Am J Physiol Heart Circ Physiol. 2013; 305:H459–H476.

23 23. Tanaka H, Seals DR. Endurance exercise performance in masters athletes: age‐associated changes and underlying physiological mechanisms. J Physiol. 2008; 586:55–63.

24 24. Ferrara N, Komici K, Corbi G, et al. β‐Adrenergic receptor responsiveness in aging heart and clinical implications. Front Physiol. 2014;4:396.

25 25. Goldspink DF. Ageing and activity: their effects on the functional reserve capacities of the heart and vascular smooth and skeletal muscles. Ergonomics. 2005; 48:1334–1351.

26 26. Fleg JL, Strait J. Age‐associated changes in cardiovascular structure and function: a fertile milieu for future disease. Heart Fail Rev. 2012; 17:545–554.

27 27. Lakatta EG, Wang M, Najjar SS. Arterial ageing and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels. Med Clin North Am. 2009; 93:583–604.

28 28. Sandow SL, Senadheera S, Grayson TH, et al. Calcium and endothelium‐mediated vasodilator signaling. Adv Exp Med Biol. 2012; 740:811–831.

29 29. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension. 2005; 46:454–462.

30 30. Thorin E, Thorin‐Trescases N. Vascular endothelial ageing, heartbeat after heartbeat. Cardiovasc Res. 2009; 84:24–32.

31 31. Lim MA, Townsend RR. Arterial compliance in the elderly: its effect on blood pressure measurement and cardiovascular outcomes. Clin Geriatr Med. 2009; 25:191–205.

32 32. Izzo JL Jr. Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol. 2004; 19:341–352.

33 33. Morley JE, McKee A. Endocrinology of aging. In: Fillit HM, Rockwood K, Young J, eds. Brocklehurst’s Textbook of Geriatric Medicine and Gerontology. 8th ed. Elsevier; 2017:139.

34 34. Rozing MP, Houwing‐Duistermaat JJ, Slagboom PE, et al. Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab. 2010; 95:4979–4984.

35 35. Aztmon G, Barzilai N, Surks MI, et al. Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. J Clin Endocrinol Metab. 2009; 94:4768–4775.

36 36. Veldhuis JD, Bowers CY. Human GH pulsatility: An ensemble property regulated by age and gender. J Endocrinol Invest. 2003; 26:799–813.

37 37. Maison P, Balkau B, Simon D, et al. Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study. BMJ. 1998; 316:1132–1133.

38 38. Haren MT, Malmstrom TK, Banks WA, et al. Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle‐aged to older African American women. Maturitas. 2007; 57:347–360.

39 39. Prentice RL, Anderson GL. The Women’s Health Initiative: lessons learned. Annu Rev Public Health. 2008; 29:131–150.

40 40. Yassin DJ, El Douaihy Y, Yassin AA, et al. Lower urinary tract symptoms improve with testosterone replacement therapy in men with late‐onset hypogonadism: 5–year prospective, observational and longitudinal registry study. World J Urol. 2014; 32:1049–1054.

41 41. Matsumoto AM. Testosterone administration in older men. Endocrinol Metab Clin North Am. 2013; 42:271–286.

42 42. Varadhan R, Walston J, Cappola AR, et al. Higher levels and blunted diurnal variation of cortisol in frail older women. J Gerontol. A Biol Sci Med Sci. 2008; 63:190–195.

43 43. Weidmann P, De Myttenaere‐Burztein S, Maxwell MH, et al. Effect of aging on plasma renin and aldosterone in normal man. Kidney Int. 1975; 8:325–333.

44 44. Findley T. Role of the neurohypophysis in the pathogenesis of hypertension and some allied disorders associated with aging. Am J Med. 1949; 7:70–84.

45 45. Dharmarajan TS, Pitchumoni CS, Kokkat AJ. The aging gut. Pract Gastroenterol. 2001; 25:15–27.

46 46. Morley JE. The aging gut: physiology. Clin Geriatr Med. 2007; 23:757–767.

47 47. Dharmarajan TS, Ugalino JT, Kathpalia R. Anorexia in older adults: consequences of aging or disease? Pract Gastroenterol. 1999; 23:82–92.

48 48. Brandt LJ. In Capell MS, Upper gastrointestinal diseases and the elderly: an interview. Intern Med World Rep. 1995; 10(Suppl):1–2.

49 49. Kao CH, Lai TL, Wang SJ, et al. Influence of age on gastric emptying in healthy Chinese. Clin Nucl Med. 1994; 19:401–404.

50 50. Holt PR. Intestinal malabsorption in the elderly. Dig Dis. 2007; 25:144–150.

51 51. Elmadfa I, Meyer AL. Body composition, changing physiological functions and nutrient requirements of the elderly. Ann Nutr Metab. 2008; 52(Suppl 1):2–5.

52 52. Eisborg L. Reversible malabsorption of folic acid in the elderly with nutritional folate deficiency. Acta Haematol. 1976; 55:140–147.

53 53. Madsen JL, Graff J. Effects of ageing on gastrointestinal motor function. Age Ageing. 2004; 33:154–159.

54 54. Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017; 474(11):1823–1836.

55 55. Popper H. Aging and the liver. In: Popper H and Schaffner F, eds. Progress in Liver Disease. 8th ed. Grune and Stratton; 1986:659–683.

56 56. Affronti J. Biliary disease in the elderly patient. Clin Geriatr Med. 1999; 15:571–578.

57 57. Gloor B, Ahmed Z, Uhl W. Pancreatic disease in the elderly. Best Pract Res Clin Gastroenterol. 2002; 16:159–170.

58 58. Harewood GC, Lawlor GO, Larson MV. Incident rates of colonic neoplasia in older patients: when should we stop screening? J Gastroenterol Hepatol. 2006; 21:1021–1025.

59 59. Zhou XJ, Rakheja D, Yu X, et al. The aging kidney. Kidney Int. 2008; 74:710–720.

60 60. Rowe JW, Andres R, Tobin JD, et al. The effect of age on creatinine clearance in men: a cross‐sectional and longitudinal study. J Gerontol. 1976; 31:155–163.

61 61. Giannelli SV, Patel KV, Windham BG, et al. Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc. 2007; 55:816–823.

62 62. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001; 37:79–83.

63 63. Hollenberg NK, Adams DF, Solomon HS, et al. Senescence and the renal vasculature in normal man. Circ Res 1974; 34:309–316.

64 64. Kuchel GA. Aging and homeostatic regulation. In: Halter JB, Hazzard WR, Ouslander JG et al, eds. Hazzard’s Principles of Geriatric Medicine And Gerontology. 3rd ed. McGraw Hill; 2008.

65 65. Rule AD, Jacobson DJ, McGree ME, et al. Longitudinal changes in post‐void residual and voided volume among community dwelling men. J Urol. 2005; 174:1317–1321.

66 66. Ustinova EE, Fraser MO, Pezzone MA Cross‐talk and sensitization of bladder afferent nerves. Neurourol Urodyn. 2010; 29:77–81.

67 67. Kuchel GA, Moscufo N, Guttmann CR, et al. Localization of brain white matter hyperintensities and urinary incontinence in community‐dwelling older adults. J Gerontol. A Biol Sci Med Sci. 2009; 64:902–909.

68 68. Smith PP, Chalmers DJ, Feinn RS. Does defective volume sensation contribute to detrusor underactivity? Neurourol Urodyn. 2015; 34:752–756. doi: 10.1002/nau.22653.

69 69. Gunes S, et al. Effects of aging on the male reproductive system. J Assist Reprod Genet. 2016; 33(4):441–54.

70 70. Shirasuna K, Iwata H. Effect of aging on the female reproductive function. Contracept Reprod Med. 2017; 2:23.

71 71. Ventura MT, et al. Immunosenescence in aging: between immune cells depletion and cytokines up‐regulation. Clin Mol Allergy. 2017; 15:21.

72 72. Xia S, et al. An update on inflamm‐aging: mechanisms, prevention, and treatment. J Immunol Res. 2016:8426874.

73 73. Kevorkian RT, Morley JE. The physiology of ageing. In: Sinclair AJ, Morley JE, Vellas B, eds. Pathy’s Principles and Practice of Geriatric Medicine. 5th ed. John Wiley and Sons, Ltd. Wiley‐Blackwell; 2012:38.

74 74. Pouilles JM, Tremollieres F, Ribot C. Effect of menopause on femoral and vertebral bone loss. J Bone Miner Res. 1995; 10:1531–1536.

75 75. Todd RC, Freeman MA, Pirie CJ. Isolated trabecular fatigue fractures in the femoral head. J Bone Joint Surg Br. 1972; 54:723–728.

76 76. Oxlund H, Mosekilde L, Ortoft G. Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone. 1996; 19:479–484.

77 77. Nakashima T, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011; 17:1231–1234.

78 78. Yeung RS. The osteoprotegerin/osteoprotegerin ligand family: role in inflammation and bone loss. J Rheumatol. 2004; 31:844–846.

79 79. Gaudio A, et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilizationinduced bone loss. J Clin Endocrinol Metab. 2010; 95:2248–2253.

80 80. Fox AJS, Bedi A, Rodeo SA. The basic science of articular cartilage. Sports Health. 2009; 1:461–468.

81 81. Antoniou J, et al. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest. 1996; 98:996–1003.

82 82. Iannuzzi‐Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol. A Biol Sci Med Sci. 2002; 57:M772–M777

83 83. Girgis C, Mokbel N, DiGirolamo D. Therapies for musculoskeletaldisease: can we treat two birds with one stone? Curr Osteoporos Rep. 2014; 12:142–153.

84 84. Cruz‐Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48(1):16–31.

85 85. Rahman I, Morrison D, Donaldson K, et al. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med. 1996; 154(Pt):1055–1060.

86 86. Lambeth JD. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med. 2007; 43:332–347.

87 87. Kelly FJ. Vitamins and respiratory disease: antioxidant micronutrients in pulmonary health and disease. Proc Nutr Soc. 2005; 64:510–526.

88 88. Verbeken EK, Cauberghs M, Mertens I, et al. The senile lung: comparison with normal and emphysematous lungs. 1: structural aspects. Chest. 1992; 101:793–799.

89 89. Leech JA, Dullberg C, Kellie S, et al. Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis. 1990; 141:68–71.

90 90. Swanney MP1, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008; 63:1046–1051.

91 91. Stubbings AK, Moore AJ, Dusmet M, et al. Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease. J Physiol. 2008; 586:2637–2650.

92 92. García‐Río F, Villamor A, Gómez‐Mendieta A, et al. The progressive effects of ageing on chemosensitivity in healthy subjects. Respir Med. 2007; 101:2192–2198.

93 93. Shaykhiev R, Crystal RG. Innate immunity and chronic obstructive pulmonary disease: a mini‐review. Gerontology. 2013; 59:481–489.

94 94. Gomez CR, Boehmer ED, Kovacs EJ. The aging innate immune system. Curr Opin Immunol. 2005; 17:457–462.

95 95. Harvell JD, Maibach HI. Percutaneous absorption and inflammation in aged skin: a review. J Am Acad Dermato.l 1994; 31:1015–1021.

96 96. Oikarinen A. The aging of skin: chronoaging versus photoaging. Photodermatol Photoimmunol Photomed. 1990; 7:3–4.

97 97. Landau M. Exogenous factors in skin aging. Curr Probl Dermatol. 2007; 35:1–13.

98 98. Waller JM, Maibach HI. Age and skin structure and function, a quantitative approach (I): blood flow, pH, thickness, and ultrasound echogenicity. Skin Res Technol. 2005; 11:221–235.

99 99. Varani J, Spearman D, Perone P, et al. Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase‐degraded collagen in vitro. Am J Pathol. 2001; 158:931–942.

100 100. Farage MA, Miller KW, Maibach HI. Degenerative changes in aging skin. In: Farage MA, Miller KW, and Maibach HI, eds. Textbook of Aging Skin. Springer‐Verlag; 2010:25–35.